Ajanta Pharma Ltd.
BSE: 532331 | Sector: Health care |
NSE: AJANTPHARM | ISIN Code: INE031B01049 |
BSE 11:39 | 25 May | 1698.80 |
-0.50 (-0.03%) |
OPEN
1703.35 |
HIGH
1703.35 |
LOW
1669.30 |
NSE 11:29 | 25 May | 1701.50 |
1.10 (0.06%) |
OPEN
1709.30 |
HIGH
1709.30 |
LOW
1668.55 |
OPEN | 1703.35 |
PREVIOUS CLOSE | 1699.30 |
VOLUME | 1509 |
52-Week high | 2420.00 |
52-Week low | 1593.30 |
P/E | 20.16 |
Mkt Cap.(Rs cr) | 14,508 |
Buy Price | 1699.80 |
Buy Qty | 1.00 |
Sell Price | 1701.55 |
Sell Qty | 10.00 |
Ajanta Pharma Ltd. (AJANTPHARM) - Company Information
Ajanta Pharma is a specialty pharmaceutical company engaged in development manufacture and marketing of quality finished dosages in domestic and international markets. The company produces a comprehensive range of specialty products targeting different therapeutic segments. The company's business includes Branded Generics in emerging markets of Asia and Africa Generics in the developed markets of ...> More
COMPANY INFORMATION | |||||||
Chairman : | Mannalal B Agrawal | ||||||
Vice Chairman : | Madhusudan B Agrawal | ||||||
Managing Director : | Yogesh Agrawal | ||||||
Independent Director : | Chandrakanth M Khetan | ||||||
Company Secretary : | Gaurang Shah | ||||||
Joint Managing Director : | Rajesh M Agrawal | ||||||
Independent Director : | K H Viswanathan | ||||||
Independent Director : | Prabhakar Dalal | ||||||
Independent Director : | Anjana Grewal | ||||||
AUDITOR : | BSR & Co LLP | ||||||
IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
HOUSE NAME : | Indian Private | ||||||
Registered office | |||||||
Ajanta House, Charkop Kandivli (W),Mumbai,Maharashtra-400067 | |||||||
Ph : 91-22-66061000/1204/1203 | |||||||
WEBSITE : http://www.ajantapharma.com | |||||||
E-mail : info@ajantapharma.com |
Quick Links for Ajanta Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices